Drugs / Passiflora
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01178632 | Oct 2010 → Dec 2011 | generalized anxiety disorder | Millet Roux | Unknown | No outcome recorded |
| Phase 3 | NCT00944268 | Sep → Dec 2009 | anxiety | Ativus Farmaceutica Ltda | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Passiflora | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01178632 ↗ |
| Known as | Passiflora, Crataegus e Salix | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00944268 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Herbal Medicine” NCT01178632 ↗ |
| Route | Oral | “01 tablet Passiflora p.o., b.i.d.” NCT01178632 ↗ |